Which factor is NOT part of the assessment of risk process?

In the assessment of risk process related to hazardous drugs as outlined in USP 800, several critical factors are considered to determine the potential risk to healthcare workers and the environment. Among these factors, the type of hazardous drug, dosage form, and risk of exposure are all relevant because they directly influence how the drug is handled, the level of protective measures needed, and potential health impacts.

The type of hazardous drug informs the classification of the drug based on its effects, whether it is a carcinogen, teratogen, or reproductive toxin, and consequently, the risk it poses. The dosage form also plays a role, as different forms (e.g., tablets, powders, injectables) have varying levels of exposure risk during compounding and administration. Additionally, the risk of exposure is assessed through potential routes of exposure (inhalation, dermal contact, etc.) and the frequency of handling.

On the other hand, drug costs do not influence the risk assessment process itself. While costs can impact decisions regarding procurement and budgeting, they do not affect the fundamental assessment of how hazardous a drug may be or the necessary precautions that need to be in place when handling it. Therefore, drug costs are not a part of the risk assessment process.